In-vitro Benchmarking of Currently Available Heart Valve Prostheses for Surgical and Percutaneous Treatment of Aortic Stenosis With Small Annulus, Followed by In-vivo Validation
IRCCS Policlinico S. Donato
300 participants
Feb 7, 2025
INTERVENTIONAL
Conditions
Summary
The general objective of this study is to compare in vitro and in vivo the hemodynamic performance of different types of aortic valve prostheses and possible surgical implantation techniques. The study involves the collection of data deriving from tests and procedures foreseen by normal clinical practice, including a transthoracic color Doppler echocardiogram, to which is added a 4DFlow cardiac MRI (magnetic resonance imaging) without contrast medium, to be performed between 1 and 3 months after the operation. The study will last 24 months and the patients involvement will end approximately 1-3 months after the intervention. There are no direct benefits expected from participation in the study. However, the instrumental data obtained by echocardiogram and Magnetic Resonance Imaging will be useful for monitoring the medium-term surgical outcome of patients after surgery.
Eligibility
Inclusion Criteria2
- patients who underwent SAVR or TAVI for severe aortic stenosis
- implanted with valve models and sizes among those which we evaluated in vitro
Exclusion Criteria7
- treated or untreated aortic root/ascending aorta aneurysm
- preoperative aortic regurgitation more than moderate
- recent (<12 weeks)/ concomitant revascularization
- recent (<12 weeks) ACS
- PPI (permanent pacemaker implantation)
- other than sinus rythm
- Paravalvular leak (PVL) > moderate.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The patients will be undergo to a MRI without contrast after 1 month from the procedure/surgery to test the hwmodynamic performance 4d flow in the implanted valve
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06859255